4d Pharma PLC - Blautix Phase II Clinical Trial Results Published

RNS Number: 5007 G 4 d Pharma PLC 16 November 2022 4 D pharma's Blautix ® Phase II Clinical Trial Results Published in Alimentary Pharmacology& Therapeutics. Leeds, UK- November 15, 2022- 4 D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products, a novel class of drug derived from the microbiome, today announced the...